ICU Medical 過去の業績

過去基準チェック /06

ICU Medicalの収益は年間平均-60.4%の割合で減少していますが、 Medical Equipment業界の収益は年間減少しています。収益は年間1.1% 16.5%割合で増加しています。

主要情報

-60.4%

収益成長率

-60.1%

EPS成長率

Medical Equipment 業界の成長	4.3%
収益成長率	16.5%
株主資本利益率	-5.4%
ネット・マージン	-4.7%
前回の決算情報	30 Sep 2024

Recent updates

収支内訳

ICU Medical の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

DB:IC7 収益、費用、利益 ( )USD Millions
日付	収益	収益	G+A経費	研究開発費
30 Sep 24	2,340	-111	635	89
30 Jun 24	2,304	-71	620	89
31 Mar 24	2,257	-59	612	87
31 Dec 23	2,259	-30	607	85
30 Sep 23	2,249	-28	595	86
30 Jun 23	2,294	-48	600	89
31 Mar 23	2,306	-46	608	89
31 Dec 22	2,280	-74	608	93
30 Sep 22	2,043	-39	547	83
30 Jun 22	1,781	5	468	72
31 Mar 22	1,541	41	383	61
31 Dec 21	1,316	103	303	47
30 Sep 21	1,296	109	295	46
30 Jun 21	1,279	103	291	44
31 Mar 21	1,260	94	284	43
31 Dec 20	1,271	87	284	43
30 Sep 20	1,266	81	281	44
30 Jun 20	1,255	83	276	46
31 Mar 20	1,264	87	277	47
31 Dec 19	1,266	101	277	49
30 Sep 19	1,291	73	283	50
30 Jun 19	1,311	47	294	51
31 Mar 19	1,359	55	308	53
31 Dec 18	1,400	29	320	53
30 Sep 18	1,430	86	321	53
30 Jun 18	1,446	86	321	53
31 Mar 18	1,417	18	324	52
31 Dec 17	1,293	69	302	51
30 Sep 17	1,018	28	249	40
30 Jun 17	772	47	195	31
31 Mar 17	537	101	132	21
31 Dec 16	379	63	89	13
30 Sep 16	372	59	89	14
30 Jun 16	361	56	87	15
31 Mar 16	348	53	85	15
31 Dec 15	340	45	83	16
30 Sep 15	329	47	81	17
30 Jun 15	321	37	83	18
31 Mar 15	316	29	87	19
31 Dec 14	307	26	89	18
30 Sep 14	306	32	89	17
30 Jun 14	311	37	90	15
31 Mar 14	311	38	89	14
31 Dec 13	312	40	89	12

質の高い収益: IC7は現在利益が出ていません。

利益率の向上: IC7は現在利益が出ていません。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: IC7は利益が出ておらず、過去 5 年間で損失は年間60.4%の割合で増加しています。

成長の加速: IC7の過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: IC7は利益が出ていないため、過去 1 年間の収益成長をMedical Equipment業界 ( 10.1% ) と比較することは困難です。

株主資本利益率

高いROE: IC7は現在利益が出ていないため、自己資本利益率 ( -5.42% ) はマイナスです。

ICU Medical 過去の業績

過去 基準チェック /06

主要情報

最近の業績更新

Third quarter 2024 earnings released: US$1.35 loss per share (vs US$0.30 profit in 3Q 2023)

ICU Medical, Inc. to Report Q3, 2024 Results on Nov 12, 2024

ICU Medical, Inc. to Report Q2, 2024 Results on Aug 07, 2024

First quarter 2024 earnings released: US$1.63 loss per share (vs US$0.41 loss in 1Q 2023)

ICU Medical, Inc. to Report Q1, 2024 Results on May 07, 2024

Full year 2023 earnings released: US$1.23 loss per share (vs US$3.11 loss in FY 2022)

Recent updates

Third quarter 2024 earnings released: US$1.35 loss per share (vs US$0.30 profit in 3Q 2023)

ICU Medical, Inc. Revises Earnings Guidance for the Year 2024

ICU Medical, Inc. Revises Earnings Guidance for the Year 2024

ICU Medical, Inc. to Report Q3, 2024 Results on Nov 12, 2024

ICU Medical, Inc. Appoints Daniel Woolson as President

Insider recently sold €369k worth of stock

Now 22% undervalued

New minor risk - Share price stability

ICU Medical, Inc. Updates Earnings Guidance for the Fiscal Year 2024

Insufficient new directors

ICU Medical, Inc. to Report Q2, 2024 Results on Aug 07, 2024

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell 1000 Dynamic Index

Chief Operating Officer recently sold €1.2m worth of stock

First quarter 2024 earnings released: US$1.63 loss per share (vs US$0.41 loss in 1Q 2023)

ICU Medical, Inc. Provides Updated Unaudited Earnings Guidance for the Year 2024

ICU Medical, Inc. to Report Q1, 2024 Results on May 07, 2024

ICU Medical, Inc., Annual General Meeting, May 15, 2024

ICU Medical, Inc. Announces the Resignation of Bill Seeger as Nominated Director

Chief Operating Officer recently sold €1.3m worth of stock

ICU Medical, Inc. Announces Resignation of William Seeger from Board of Director and Member of the Audit and Compliance Committee

Full year 2023 earnings released: US$1.23 loss per share (vs US$3.11 loss in FY 2022)

ICU Medical, Inc. to Report Q4, 2023 Results on Feb 27, 2024

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from S&P 400 Health Care (Sector)

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: US$0.30 (vs US$0.55 loss in 3Q 2022)

ICU Medical, Inc. to Report Q3, 2023 Results on Nov 06, 2023

Chief Operating Officer recently sold €825k worth of stock

ICU Medical Inc. Receives FDA Clearance for Plum Duo Infusion Pump and LifeShield Infusion Safety Software

Icu Medical, Inc. Provides Earnings Guidance for the Fiscal Year 2023

Second quarter 2023 earnings released: US$0.41 loss per share (vs US$0.31 loss in 2Q 2022)

ICU Medical, Inc. to Report Q2, 2023 Results on Aug 07, 2023

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell Small Cap Comp Growth Index

First quarter 2023 earnings released: US$0.41 loss per share (vs US$1.61 loss in 1Q 2022)

Now 20% undervalued after recent price drop

Full year 2022 earnings released: US$3.11 loss per share (vs US$4.86 profit in FY 2021)

ICU Medical, Inc. to Report Q4, 2022 Results on Feb 27, 2023

Third quarter 2022 earnings released: US$0.55 loss per share (vs US$1.47 profit in 3Q 2021)

ICU Medical, Inc. Reaffirms Earnings Guidance for the Full Year 2022

ICU Medical, Inc. to Report Q3, 2022 Results on Nov 07, 2022

Second quarter 2022 earnings released: US$0.31 loss per share (vs US$1.34 profit in 2Q 2021)

ICU Medical, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Corporate VP recently sold €125k worth of stock

First quarter 2022 earnings released: US$1.61 loss per share (vs US$1.12 profit in 1Q 2021)

ICU Medical, Inc. to Report Q1, 2022 Results on May 09, 2022

ICU Medical, Inc., Annual General Meeting, May 17, 2022

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

ICU Medical, Inc. Provides Earnings Guidance for the Fiscal Year 2022

ICU Medical, Inc. Announces Executive changes, Effective March 18, 2022

ICU Medical, Inc. to Report Q4, 2021 Results on Feb 24, 2022

ICU Medical, Inc. Announces Appointment of William Seeger as Director, Member of Audit and Compliance Committee

ICU Medical, Inc. (NasdaqGS:ICUI) completed the acquisition of Smiths Medical, Inc. from Smiths Group plc (LSE:SMIN).

Insufficient new directors

Third quarter 2021 earnings released: EPS US$1.47 (vs US$1.19 in 3Q 2020)

Corporate VP recently sold €170k worth of stock

Investor sentiment improved over the past week

ICU Medical, Inc. (NasdaqGS:ICUI) entered into an agreement to acquire Smiths Medical Division from Smiths Group plc (LSE:SMIN) for $2.5 billion.

ICU Medical, Inc. Issues Voluntary Nationwide Recall of Aminosyn II 15%, an Amino Acid Injection, Sulfite Free IV Solution Due to the Presence of Particulate Matter

ICU Medical, Inc. Provides Earnings Guidance for the Fiscal Year 2021

Second quarter 2021 earnings released: EPS US$1.34 (vs US$0.91 in 2Q 2020)

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell 1000 Growth Index

Independent Director recently sold €251k worth of stock

Corporate VP recently sold €162k worth of stock

First quarter 2021 earnings released: EPS US$1.12 (vs US$0.81 in 1Q 2020)

Independent Director recently sold €257k worth of stock

Full year 2020 earnings released: EPS US$4.16 (vs US$4.90 in FY 2019)

ICU Medical, Inc. to Report Q4, 2020 Results on Feb 25, 2021

New 90-day high: €178

New 90-day high: €174

Revenue beats expectations

過去基準チェック /06